Job Title:  MSL Central-South Italy

Job Requisitions No.:  19155
Job Description: 

Role Details

The MSL serves to advance science and standards of care for patients, healthcare providers and payers, and ensure they can access all the practical and clinically relevant information and solutions they need to use Accord Healthcare’s Products efficiently and safely.
Medical Science Liaisons (MSL) is key member of the EMENA Medical Operations/Medical Affairs part of Regulatory Affairs department supporting the local Medical Affairs needs.
The MSLs are field-based scientific expert to external and internal stakeholders delivering scientific/non-promotional information exchange and supporting scientific data and insight generation to provide HCPs/Patients solutions regarding all on-market and in-development Accord Healthcare Products, including those that have been in-licensed, or on topics relating to disease states.
They are responsible for developing and implementing needs facing medical strategies and have a primary liaison role to the medical and scientific community.
The MSL must maintain up-to-date knowledge of relevant scientific information.
The MSL works in coordination with the rest of the Medical unit to meet the Medical Affairs objectives.
The MSL is expected to comply with all Accord Healthcare Processes and any relevant National guidelines*.
*The European Federation of Pharmaceutical Industries and Associations (EFPIA) Code of Practice, as well as the EU Directive 2001/83/EC and Members' national codes and local regulations, guide the interactions between the pharmaceutical industry/MSL and HCPs/Patients Association.

The Role

Establish and foster professional collaborations with the Healthcare community:
Map the scientific expertise: Identify, complete and update Thought Leaders (TL) database in the disease area in accordance with the Medical Operations and Medical Affairs Therapeutic Areas directives,
Conduct fair and balanced scientific exchanges with TL to explore mutual clinical and scientific interests, insights generation, scientific/educational meetings (congresses, symposia, etc.), potential research collaborations,
Identify opportunities for collaboration with TL when aligned with Accord Healthcare strategy,
Develop and enhance scientific and educational collaborations with HealthCare Professionals (HCPs) within the Healthcare community and act as a medical contact for TL and external medical experts,
Reactively interact to unsolicited and documented queries/requests for information from HCPs.
Develop and/or implement unbiased and non‐promotional scientific exchange meetings and educational activities:
Provide scientific/educational presentations to HCP:
Reactively on ACCORD products (on‐label & off‐label indications), or on Accord Healthcare compounds in development,
Proactively on ACCORD products (on‐label single‐product presentation) but mainly on disease area management,
Organize or support legitimate scientific exchange meetings,
Contribute to/implement medical education programs in the field,
Contribute to the scientific publication program, if required,
Organize satellite symposia in regional (in‐country) congresses.
Generate and share insight from HCP to nurture Accord Healthcare’s strategy:
Collect, analyse, and report actionable scientific insight from HCP related to disease state, unmet medical needs, local guidelines, therapeutic trends, competitive activities, compounds in development and the broader healthcare environment,
If appropriate, organise or support Advisory Boards at Regional level (in‐country),
Attend and report insights from major National and Regional medical congresses,
Engage and collaborate on specific initiatives with patient organisations in accordance with external/internal global and local guidance’s on Interactions with Patient Organisations and individual patients,
Contribute to the dissemination of the information within the Company where appropriate,
Report spontaneous adverse events and product‐related quality complaints in accordance to global and local Accord Healthcare SOP and the local law.
Support to clinical development & ISS (data generation):
Coordinate and facilitate unsolicited Investigator Initiated Trials (IIT) requests from submission until completion, presentation, and publication, in alignment with Medical Affairs’ objectives,
Support the Accord Healthcare/ICTAS Sponsored Studies (Phase I to IV) operations (see attached Annex), when appropriate,
Identify and drive opportunities to generate real‐world‐evidence data.
Ensure internal cross‐functional collaborations as a scientific partner:
Develop Local Medical Plans,
Develop publication and scientific project plan
Set-up and schedule medical ad board
Develop local standard responses, if required (in coordination with Medical Information Department).


The Person

Action Oriented - Pushes self-outside of comfort zone to take action when needed,
Peer Relationships - Professional and respectful in interactions with others at all times,
Drive for Results - Delivers results as it relates to the specific task or situation,
Customer Focus - Builds good relationships with customers.

Experience in delivery of scientific presentations and development of relationships with Thought Leaders is strongly preferred,
Ideally, knowledge in data analysis and statistics for purpose of understanding clinical study results,
Ideally, current working knowledge of legal, regulatory, and compliance regulations and guidelines relevant to industry interactions with health-care professionals,
Expert/fluent communicator in their local language and excellent knowledge of written and spoken scientific English,
Computer literacy,
Driving licence.

The Rewards

  • Base Salary between 55.000 and 65.000 
  • Incentive Bonus 10%
  • Lunch Allowance
  • Company Car 
  • Conituous training  

 

How to Apply

A Bit About Us

Footer

All applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or disability.

Requisition ID: [[id]]

Location: 

IT

Travel:  75% - 100%
Date:  29 Oct 2026